Xwell has 7 Schedule 13D or 13G filings on record since 2026-03-11. 4 holders' latest filing reports 5% or more of common stock, par value $0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| American Ventures LLC, Series XXIV XWELL | 9.98% | 993,617 | SCHEDULE 13D/A, 2026-09-08 | 2026-09-08 |
| Bruce Bernstein | 6.9% | 602,556 | SCHEDULE 13D, 2026-08-04 | 2025-11-15 |
| McCabe James Joseph III | 5.5% | 319,000 | SCHEDULE 13G, 2026-03-11 | 2026-02-24 |
| Richard Abbe | 5.5% | 466,944 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 |
Purpose of Transaction (Item 4)
American Ventures LLC, Series XXIV XWELL
The Reporting Persons acquired the securities described herein for investment purposes. The Reporting Persons may engage in discussions with the Issuer's management, board of directors, stockholders, and other interested parties concerning potential strategic transactions, including possible merger and acquisition opportunities. The Reporting Persons may from time to time make introductions or otherwise facilitate discussions between the Issuer and third parties regarding such potential opportunities. The Reporting Persons are in discussions with third parties that may result in one of the actions described in Item 4(a)-(j) above, however there are currently no definitive agreements to undertake such actions. Additionally, the Reporting Persons may continue to review and consider other opportunities that may present themselves from time to time, depending on various factors, including the Issuer's financial position, the price level of the securities, conditions in the securities markets, general economic and industry conditions, or other factors. On July 7, 2026, the Reporting Persons delivered notice to the Issuer to increase the Beneficial Ownership Limitation applicable to the Series H Convertible Preferred Stock from 4.99% to 9.99%, effective on the 61st day following delivery of such notice (September 7, 2026). On September 8, 2026, the Reporting Persons converted 467 shares of Series H Convertible Preferred Stock into 993,617 shares of the Issuer's common stock, …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-09-08; the filing has the rest
Bruce Bernstein
Stock Option Agreement Pursuant to the Issuer's 2020 Equity Incentive Plan (the "Plan") and the Stock Option Agreement between the Issuer and the Reporting Person (the "Stock Option Agreement"), the Reporting Person received a stock option award to purchase 30,000 shares of common stock on January 5, 2023. Such stock option award vested in equal quarterly installments over a one-year period, vesting one-fourth at the end of each fiscal quarter, such that the award fully vested as of December 31, 2023. On November 15, 2024, the Reporting Person received an additional stock option award to purchase 44,037 shares of common stock, which vested in full on the first anniversary of the date of grant. On June 2, 2025, the Reporting Person received an additional stock option award to purchase 220,528 shares of common stock, which vested in equal quarterly installments over a one-year period, vesting one-fourth at the end of each fiscal quarter, such that the award fully vested on June 2, 2026. The foregoing description of the Stock Option Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Plan and a form of the Stock Option Agreement, which are incorporated herein by reference to Exhibits 99.1 and 99.2, respectively, of this Schedule 13D. Restricted Stock Agreement Pursuant to the Plan and the Restricted Stock Agreement between the Issuer and the Reporting Person (the "RSA Agreement"), the Reporting Person received an …The first part of Item 4 of the SCHEDULE 13D filed 2026-08-04; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-11 | McCabe James Joseph III | 5.5% | SCHEDULE 13G |
| 2026-03-18 | American Ventures LLC, Series XXIV XWELL | 4.99% | SCHEDULE 13D |
| 2026-06-11 | Richard Abbe | 5.14% | SCHEDULE 13G |
| 2026-08-04 | Bruce Bernstein | 6.9% | SCHEDULE 13D |
| 2026-08-12 | Iroquois Capital Management, LLC | 0% | SCHEDULE 13G/A |
| 2026-08-13 | Richard Abbe | 5.5% | SCHEDULE 13G/A |
| 2026-09-08 | American Ventures LLC, Series XXIV XWELL | 9.98% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Xwell. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.